Entegris

In the Know: Healthcare News from Medical Alley, Feb. 1, 2019

Relievant Announces Level l INTRACEPT Study Stopped Early for Superiority Healthcare Update Forum 2019: Minnesota Needs to Lead Industry Change C Diff Foundation Recognizes Rebiotix CEO with 2019 ‘Above and Beyond’ Award Inspire Medical Systems, Inc. Announces FDA Approval of New Sensing Lead Chemicals maker Entegris to buy Versum in $4 billion microchip bet HabitAware […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER